Related references
Note: Only part of the references are listed.Altered circadian genes expression in breast cancer tissue according to the clinical characteristics
Monika Lesicka et al.
PLOS ONE (2018)
Update: Interim Guidance for Preconception Counseling and Prevention of Sexual Transmission of Zika Virus for Men with Possible Zika Virus Exposure - United States, August 2018
Kara D. Polen et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
Beyond DNA: the Role of Epigenetics in the Premalignant Progression of Breast Cancer
Rebecca S. DeVaux et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2018)
Predicting the molecular subtype of breast cancer based on mammography and ultrasound findings
S. Rashmi et al.
INDIAN JOURNAL OF RADIOLOGY AND IMAGING (2018)
Circadian gene methylation in rotating-shift nurses: a cross-sectional study
Edyta Reszka et al.
CHRONOBIOLOGY INTERNATIONAL (2018)
Artificial Light at Night of Different Spectral Compositions Differentially Affects Tumor Growth in Mice: Interaction With Melatonin and Epigenetic Pathways
A. E. Zubidat et al.
CANCER CONTROL (2018)
Case-control study of candidate gene methylation and adenomatous polyp formation
M. Alexander et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2017)
Epigenetic plasticity and the hallmarks of cancer
William A. Flavahan et al.
SCIENCE (2017)
Mechanisms of Breast Cancer in Shift Workers: DNA Methylation in Five Core Circadian Genes in Nurses Working Night Shifts
Johanna Samulin Erdem et al.
JOURNAL OF CANCER (2017)
CRY2 is suppressed by FOXM1 mediated promoter hypermethylation in breast cancer
Lingling Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Epigenetic regulation of the circadian clock: role of 5-aza-2′-deoxycytidine
Tatsunosuke Tomita et al.
BIOSCIENCE REPORTS (2017)
Circadian clocks and breast cancer
Victoria Blakeman et al.
BREAST CANCER RESEARCH (2016)
The circadian gene CRY2 is associated with breast cancer aggressiveness possibly via epigenomic modifications
Yingying Mao et al.
TUMOR BIOLOGY (2015)
Epigenetic silencing of ARNTL, a circadian gene and potential tumor suppressor in ovarian cancer
Chia-Ming Yeh et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
DNA methylation of the BMAL1 promoter
R. Satou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors
Olaf Neumann et al.
HEPATOLOGY (2012)
Genetic and epigenetic associations of circadian gene TIMELESS and breast cancer risk
Alan Fu et al.
MOLECULAR CARCINOGENESIS (2012)
Work at night and breast cancer - report on evidence-based options for preventive actions
Jens Peter Bonde et al.
SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH (2012)
HSG cells, a model in the submandibular clock
Yoshiaki Onishi
BIOSCIENCE REPORTS (2011)
Genome-wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of Recurrence
Mary Jo Fackler et al.
CANCER RESEARCH (2011)
Epigenetic Impact of Long-Term Shiftwork: Pilot Evidence From Circadian Genes and Whole-Genome Methylation Analysis
Yong Zhu et al.
CHRONOBIOLOGY INTERNATIONAL (2011)
The Core Circadian Gene Cryptochrome 2 Influences Breast Cancer Risk, Possibly by Mediating Hormone Signaling
Aaron E. Hoffman et al.
CANCER PREVENTION RESEARCH (2010)
CLOCK in Breast Tumorigenesis: Genetic, Epigenetic, and Transcriptional Profiling Analyses
Aaron E. Hoffman et al.
CANCER RESEARCH (2010)
Estrogen and progesterone receptor status affect genome-wide DNA methylation profile in breast cancer
Lian Li et al.
HUMAN MOLECULAR GENETICS (2010)
Fine Tuning Gene Expression: The Epigenome
Davoud Mohtat et al.
SEMINARS IN NEPHROLOGY (2010)
Breast Cancer, Estrogen Receptor and Ligands
Zhenlin Bai et al.
ARCHIV DER PHARMAZIE (2009)
Epigenetic Inactivation of the Circadian Clock Gene BMAL1 in Hematologic Malignancies
Hiroaki Taniguchi et al.
CANCER RESEARCH (2009)
Disturbance of circadian gene expression in breast cancer
Shou-Jen Kuo et al.
VIRCHOWS ARCHIV (2009)
Rhythmic SAF-A binding underlies circadian transcription of the Bmal1 gene
Yoshiaki Onishi et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response
Aaron E. Hoffman et al.
MOLECULAR CANCER RESEARCH (2008)
Disturbance of Circadian Gene Expression in Hepatocellular Carcinoma
Yueh-Min Lin et al.
MOLECULAR CARCINOGENESIS (2008)
The genetics of mammalian circadian order and disorder: implications for physiology and disease
Joseph S. Takahashi et al.
NATURE REVIEWS GENETICS (2008)
The clock gene Per2 links the circadian system to the estrogen receptor
S. Gery et al.
ONCOGENE (2007)
Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors
Sherry L. Winter et al.
NEOPLASIA (2007)
Uncoupling of promoter methylation and expression of Period1 in cervical cancer cells
Min-Chuan Hsu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR
Mu-Chin Shih et al.
MOLECULAR CARCINOGENESIS (2006)
Circadian gene mPer2 overexpression induces cancer cell apoptosis
Hui Hua et al.
CANCER SCIENCE (2006)
The circadian gene Per1 plays an important role in cell growth and DNA damage control in human cancer cells
S Gery et al.
MOLECULAR CELL (2006)
Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers
ST Chen et al.
CARCINOGENESIS (2005)
Abnormal expression of Period 1 (PER1) in endometrial carcinoma
KT Yeh et al.
JOURNAL OF PATHOLOGY (2005)
Circadian disruption and breast cancer from melatonin to clock genes
RG Stevens
EPIDEMIOLOGY (2005)
Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors
P Parrella et al.
CLINICAL CANCER RESEARCH (2004)
The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo
LN Fu et al.
CELL (2002)
Mop3 is an essential component of the master circadian pacemaker in mammals
MK Bunger et al.
CELL (2000)
Share Paper
